Matthew B. Kaufmann, PhD

Matthew B. Kaufmann, PhD

Midwest Analytics and Disease Modeling Center (MADMC) Postdoctoral Associate

Sitemap

A list of all the posts and pages found on the site. For you robots out there is an XML version available for digesting as well.

Pages

Posts

Future Blog Post

less than 1 minute read

Published:

This post will show up by default. To disable scheduling of future posts, edit config.yml and set future: false.

Blog Post number 4

less than 1 minute read

Published:

This is a sample blog post. Lorem ipsum I can’t remember the rest of lorem ipsum and don’t have an internet connection right now. Testing testing testing this blog post. Blog posts are cool.

Blog Post number 3

less than 1 minute read

Published:

This is a sample blog post. Lorem ipsum I can’t remember the rest of lorem ipsum and don’t have an internet connection right now. Testing testing testing this blog post. Blog posts are cool.

Blog Post number 2

less than 1 minute read

Published:

This is a sample blog post. Lorem ipsum I can’t remember the rest of lorem ipsum and don’t have an internet connection right now. Testing testing testing this blog post. Blog posts are cool.

Blog Post number 1

less than 1 minute read

Published:

This is a sample blog post. Lorem ipsum I can’t remember the rest of lorem ipsum and don’t have an internet connection right now. Testing testing testing this blog post. Blog posts are cool.

portfolio

publications

Immunosuppression Considerations for Older Kidney Transplant Recipients

Published in Current Transplantation Reports, 2021

In this review, we discuss appropriate management of immunosuppressive agents in older adults to minimize adverse events, avoid acute rejection, and maximize patient and graft survival.

Recommended citation: Cheungpasitporn, W., Lentine, K. L., Tan, J. C., Kaufmann, M., Caliskan, Y., Bunnapradist, S., ... & Axelrod, D. A. (2021). Immunosuppression considerations for older kidney transplant recipients. Current transplantation reports, 8(2), 100-110. https://link.springer.com/article/10.1007/s40472-021-00321-6

Racial Disparities in Pediatric Kidney Transplantation under the New Kidney Allocation System in the United States

Published in Clinical Journal of the American Society of Nephrology, 2021

In December 2014, the Kidney Allocation System (KAS) was implemented to improve equity in access to transplantation, but preliminary studies in children show mixed results. Thus, we aimed to assess how the 2014 KAS policy change affected racial and ethnic disparities in pediatric kidney transplantation access and related outcomes.

Recommended citation: Krissberg, J. R., Kaufmann, M. B., Gupta, A., Bendavid, E., Stedman, M., Cheng, X. S., ... & Chaudhuri, A. (2021). Racial disparities in pediatric kidney transplantation under the new kidney allocation system in the United States. Clinical Journal of the American Society of Nephrology, 16(12), 1862-1871. https://cjasn.asnjournals.org/content/16/12/1862.abstract

Deceased Donor Kidney Transplantation for Older Transplant Candidates: A New Microsimulation Model for Determining Risks and Benefits

Published in Medical Decision Making, 2023

Under the current US kidney allocation system, older candidates receive a disproportionately small share of deceased donor kidneys despite a reserve of potentially usable kidneys that could shorten their wait times. To consider potential health gains from increasing access to kidneys for these candidates, we developed and calibrated a microsimulation model of the transplantation process and long-term outcomes for older deceased donor kidney transplant candidates.

Recommended citation: Kaufmann, M. B., Tan, J. C., Chertow, G. M., Goldhaber-Fiebert, J. D. (2023). Deceased Donor Kidney Transplantation for Older Transplant Candidates: A New Microsimulation Model for Determining Risks and Benefits. Medical Decision Making https://journals.sagepub.com/doi/10.1177/0272989X231172169

A New Type 2 Diabetes Microsimulation Model to Estimate Long-term Health Outcomes, Costs, and Cost-Effectiveness

Published in Value in Health, 2023

Existing type 2 simulation models implement risk equations derived from UK data. This model is based on newly derived risk equations developed for the United States. This model can be used to predict remaining life-years, costs, and quality-adjusted life-years for different cohorts of type 2 patients.

Recommended citation: Hoerger, T.J., Hilscher, R., Neuwahl, S., Kaufmann, M. B., Shao, H., Laxy, M., Cheng, Y.J., Benoit, S., Chen, H., Anderson, A. and Craven, T., Yang, W., Cintina,, I., Staimez., L., Zhang, P., the Look AHEAD Research Group. (2023). A New Type 2 Diabetes Microsimulation Model to Estimate Long-term Health Outcomes, Costs, and Cost-Effectiveness. Value in Health https://www.sciencedirect.com/science/article/abs/pii/S1098301523026153

research

talks

teaching

Health Policy Summer Math Camp

Graduate Bootcamp, Stanford University, School of Medicine, 2021

Lead sessions on calculus and probability theory for the student lead Health Policy Summer Math Camp in 2021, 2022, & 2023.

wip